Developer of MRI polarizers and hyperpolarized imaging agents
NVision Imaging has raised €75M across 2 funding rounds from 12 investors, most recently a Series B round in May 2026. Based in Ulm, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-13 | Series B | €47M | Abbott,Entrée Capital,European Investment Bank,Matterwave / b2ventures,other investors,Playground Global | View deal → |
| 2023-06-23 | Series A | €28M | B-to-V,Entree Capital,ES KAPITAL,Lauder Family,Pathena Investments,Playground Global+1 more | View deal → |
